Matinas BioPharma Holdings Inc. (MTNB): Dana dhuwit perusahaan

Lambang korporat lan logo matinasbiopharma.com (MTNB)

Matinas BioPharma (MTNB) is developing advanced therapies for metabolic disorders using an innovative cellular delivery system. Transitioning from injections to tablets paves the way for licensing deals with industry behemoths. The company's cash balance demonstrates financial stability, with the latest figure standing at 0.00. The business is currently implementing automated molecule screening and software robots for clinical data analysis.

MTNB - Volume dana dhuwit perusahaan Matinas BioPharma Holdings ing rentang 04.07.2022 - 21.11.2026

Rincian analitis lan laporan data perusahaan matinasbiopharma.com (MTNB)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:Matinas BioPharma Holdings, Inc.
Produk merek Matinas BioPharma

Developing oral formulations for complex drugs requires significant R&D capital expenditures. This indicator captures the total volume of liquid assets and equivalents available to Matinas BioPharma (MTNB) for operational activities. By analyzing changes in cash holdings, an investor assesses the company's financial runway. A sufficient reserve minimizes the risk of equity dilution during recapitalization. A stable cash balance confirms the business's ability to sustain its technological cycle.

Analisis perusahaan pesaing

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|Rezolute - Gunggung dana dhuwit perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis perusahaan|Dhuwit awis perusahaan MBX Bio|Dhuwit awis perusahaan ALT|AARD: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SGMT|Dana dhuwit perusahaan BIOA (BioAge Labs)|Volume dana dhuwit perusahaan BMEA (Biomea Fusion Corp)|Sisa dhuwit perusahaan QNCX|GUTS - Dana dhuwit perusahaan|VTVT - Volume dana dhuwit perusahaan|Agape ATP Corp. (ATPC) - Dana dhuwit perusahaan|Pluri Inc (PLUR) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Synlogic|Dana dhuwit perusahaan LPCN|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)